Abbott Labs Reports Director and Officer Changes

Ticker: ABT · Form: 8-K · Filed: 2025-05-01T00:00:00.000Z

Sentiment: neutral

Topics: governance, officer-changes, director-changes

Related Tickers: ABT

TL;DR

ABT filed an 8-K on director/officer changes effective 4/25.

AI Summary

Abbott Laboratories filed an 8-K on May 1, 2025, reporting changes effective April 25, 2025. The filing pertains to the departure of directors, election of directors, appointment of officers, and compensatory arrangements for certain officers. Specific details regarding individuals, dollar amounts, and exact dates of these changes are not provided in this excerpt.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.

Risk Assessment

Risk Level: low — This filing reports routine corporate governance changes and does not indicate immediate financial or operational risks.

Key Players & Entities

FAQ

What specific director positions became vacant or were filled?

The filing indicates the departure of directors and the election of directors, but the specific positions are not detailed in this excerpt.

Who are the newly appointed officers?

The filing mentions the appointment of certain officers, but their names are not provided in this excerpt.

What are the details of the compensatory arrangements for the officers?

The filing notes that compensatory arrangements for certain officers are being reported, but the specific terms and amounts are not included in this excerpt.

What was the exact date of the board and officer changes?

The date of the earliest event reported is April 25, 2025.

What is the company's standard industrial classification?

The company's standard industrial classification is Pharmaceutical Preparations [2834].

From the Filing

0001104659-25-043508.txt : 20250501 0001104659-25-043508.hdr.sgml : 20250501 20250501160121 ACCESSION NUMBER: 0001104659-25-043508 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250425 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 25902848 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 8-K 1 tm2513718d1_8k.htm FORM 8-K false 0000001800 Common Shares, Without Par Value ABT 0000001800 2025-04-25 2025-04-25 0000001800 us-gaap:CommonStockMember exch:XCHI 2025-04-25 2025-04-25 0000001800 us-gaap:CommonStockMember exch:XNYS 2025-04-25 2025-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Common Shares, Without Par Value   ABT       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549       FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   April 25, 2025 Date of Report (Date of earliest event reported)   ABBOTT LABORATORIES (Exact name of registrant as specified in charter)       Illinois   1-2189   36-0698440 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)       100 Abbott Park Road Abbott Park , Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 224 ) 667-6100   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities Registered Pursuant to Section 12(b) of the Act:   Title of Each Class Trading Symbol(s) Name of Each Exchange  on Which Registered Common Shares, Without Par Value ABT New York Stock Exchange Chicago Stock Exchange, Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company   ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨             Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Cer

View on Read The Filing